A new study found that just seeing a sick person can be enough to trigger an immune response.
Plus new updates on three-parent babies and the 23andMe acquisition.
The launch is a critical step in making a newer type of genomic data more broadly useful for a variety of healthcare needs.
It’s how science gets communicated that is holding us back.
The field of ancient genomics is thriving, supporting new discoveries about our ancestors and other hominin populations.
While tragic, the recent death in a gene therapy clinical trial highlights how far the field has come since its earliest days
From political pushback to conspiracy theories, mRNA vaccines are facing an uncertain future. That’s extremely bad news for a highly effective and safe means of protection from infectious disease.
The good news: novel antibiotics may be coming to the clinic. The bad news: they may not stay effective for long if we don’t do a better job preventing antibiotic resistance in the first place.
To paraphrase Emily Dickinson, I’m sorry this post is long — I didn’t have time to write a shorter one.
Through telemedicine, at-home sample collection tools, and better communication strategies, the benefits of participating in a clinical trial could be available to more people
At a recent cancer research conference, scientists presented new discoveries about DNA and proteins that could change how we understand — and, ultimately, treat — this disease.
At a cancer research meeting, leaders in the field urge scientists to fight for their mission and to get better at communicating the impact of their work
